Back to Browse Journals » Nanotechnology, Science and Applications » Volume 1

Applications of gold nanoparticles in cancer nanotechnology

Authors Weibo Cai, Ting Gao, Hao Hong, Jiangtao Sun

Published 19 September 2008 Volume 2008:1 Pages 17—32

DOI https://doi.org/10.2147/NSA.S3788

Review by Single-blind

Peer reviewer comments 5

Weibo Cai1,2, Ting Gao3, Hao Hong1, Jiangtao Sun1

1Departments of Radiology and Medical Physics, School of Medicine and Public Health, University of Wisconsin – Madison, Madison, Wisconsin, USA; 2University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA; 3Tyco Electronics Corporation, 306 Constitution Drive, Menlo Park, California, USA

Abstract: It has been almost 4 decades since the “war on cancer” was declared. It is now generally believed that personalized medicine is the future for cancer patient management. Possessing unprecedented potential for early detection, accurate diagnosis, and personalized treatment of cancer, nanoparticles have been extensively studied over the last decade. In this review, we will summarize the current state-of-the-art of gold nanoparticles in biomedical applications targeting cancer. Gold nanospheres, nanorods, nanoshells, nanocages, and surface enhanced Raman scattering nanoparticles will be discussed in detail regarding their uses in in vitro assays, ex vivo and in vivo imaging, cancer therapy, and drug delivery. Multifunctionality is the key feature of nanoparticle-based agents. Targeting ligands, imaging labels, therapeutic drugs, and other functionalities can all be integrated to allow for targeted molecular imaging and molecular therapy of cancer. Big strides have been made and many proof-of-principle studies have been successfully performed. The future looks brighter than ever yet many hurdles remain to be conquered. A multifunctional platform based on gold nanoparticles, with multiple receptor targeting, multimodality imaging, and multiple therapeutic entities, holds the promise for a “magic gold bullet” against cancer.

Keywords: gold nanoparticles, cancer, nanotechnology, optical imaging, nanomedicine, molecular therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Anatomical and molecular imaging of skin cancer

Hao Hong, Jiangtao Sun, Weibo Cai

Clinical, Cosmetic and Investigational Dermatology 2008, 1:1-17

Published Date: 7 October 2008

Readers of this article also read:

Chitosan–tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity

Servat-Medina L, González-Gómez A, Reyes-Ortega F, Sousa IMO, Queiroz NCA, Zago PMW, Jorge MP, Monteiro KM, de Carvalho JE, San Román J, Foglio MA

International Journal of Nanomedicine 2015, 10:3897-3909

Published Date: 9 June 2015

Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Hainan population: a case-control study

Ding YP, Yang DL, Xun XJ, Wang ZF, Sun P, Xu DC, He P, Niu H, Jin TB

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:7-13

Published Date: 17 December 2014

Antidepressants in primary care: patients’ experiences, perceptions, self-efficacy beliefs, and nonadherence

Wouters H, Bouvy ML, Van Geffen ECG, Gardarsdottir H, Stiggelbout AM, Van Dijk L

Patient Preference and Adherence 2014, 8:179-190

Published Date: 10 February 2014

Umbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: application for in vivo cell tracking

Sibov TT, Pavon LF, Miyaki LA, Mamani JB, Nucci LP, Alvarim LT, Silveira PH, Marti LC, Gamarra LF

International Journal of Nanomedicine 2014, 9:337-350

Published Date: 8 January 2014

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma

Mizoguchi T, Ozaki M, Unoki K, Dake Y, Eto T, Arai M

Clinical Ophthalmology 2012, 6:1579-1584

Published Date: 25 September 2012

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center

Shammas NW, Shammas GA , Nader E, Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S

Vascular Health and Risk Management 2012, 8:205-211

Published Date: 11 April 2012

Amino acid-responsive Crohn's disease: a case study

Alvin Stein, Marty Hinz, Thomas Uncini

Clinical and Experimental Gastroenterology 2010, 3:171-177

Published Date: 6 December 2010

Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care

Frederic Kontny, Terje Risanger, Arne Bye, et al

Vascular Health and Risk Management 2010, 6:31-38

Published Date: 15 January 2010

Gold nanoparticles: From nanomedicine to nanosensing

Po C Chen, Sandra C Mwakwari, Adegboyega K Oyelere

Nanotechnology, Science and Applications 2008, 1:45-66

Published Date: 2 November 2008